HCA Healthcare (NYSE:HCA) Releases FY 2025 Earnings Guidance

Key Points

• HCA Healthcare has updated its FY 2025 earnings guidance, projecting earnings per share between $25.500 and $27.000, slightly above the consensus estimate of $25.343.
• The company also expects revenue of $74.0 billion to $76.0 billion, which is below analysts' consensus expectation of $74.7 billion.
• Research analysts show a mixed outlook on HCA, with recent upgrades from Wells Fargo and Stephens, while the average consensus target price is $399.46 and has a rating of "Moderate Buy."

HCA Healthcare (NYSE:HCA - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 25.500-27.000 for the period, compared to the consensus estimate of 25.343. The company issued revenue guidance of $74.0 billion-$76.0 billion, compared to the consensus revenue estimate of $74.7 billion.

HCA Healthcare Trading Down 2.1%

Shares of NYSE:HCA traded down $7.22 during mid-day trading on Friday, reaching $334.26. 3,175,863 shares of the company were exchanged, compared to its average volume of 1,334,458. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm's 50-day simple moving average is $373.81 and its 200 day simple moving average is $345.92. HCA Healthcare has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market cap of $80.41 billion, a price-to-earnings ratio of 14.05, a P/E/G ratio of 1.17 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the firm posted $5.50 earnings per share. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts forecast that HCA Healthcare will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Wall Street Analysts Forecast Growth

Several research firms have commented on HCA. Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Barclays set a $416.00 price target on HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Finally, Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Eight investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $399.46.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company's stock.

Institutional Trading of HCA Healthcare

An institutional investor recently bought a new position in HCA Healthcare stock. Brighton Jones LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,402 shares of the company's stock, valued at approximately $1,021,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.